Janus Henderson Group PLC Verona Pharma PLC Transaction History

Janus Henderson Group PLC

$174 Billion
Q1 2025

A detailed history of Janus Henderson Group PLC transactions in Verona Pharma PLC stock. As of the latest transaction made, Janus Henderson Group PLC holds 5,516,889 shares of VRNA stock, worth $497 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

5,516,889

Previous 1,667,165 230.91%

Holding current value

$497 Million

Previous $77.4 Million 352.41%

% of portfolio

0.2%

Previous 0.04%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$44.81 - $69.63 $173 Million - $268 Million	3,849,724 Added 230.91%	5,516,889 $350 Million
Q4 2024 Feb 14, 2025	BUY	$28.71 - $47.02 $17.9 Million - $29.4 Million	624,370 Added 59.87%	1,667,165 $77.4 Million
Q3 2024 Nov 14, 2024	SELL	$15.46 - $30.16 $761,358 - $1.49 Million	-49,247 Reduced 4.51%	1,042,795 $30 Million
Q2 2024 Aug 14, 2024	SELL	$11.48 - $17.02 $10.8 Million - $16 Million	-939,952 Reduced 46.26%	1,092,042 $15.8 Million
Q1 2024 May 15, 2024	BUY	$15.3 - $20.24 $3.5 Million - $4.63 Million	228,633 Added 12.68%	2,031,994 $32.7 Million
Q4 2023 Feb 14, 2024	BUY	$11.94 - $20.47 $1.99 Million - $3.41 Million	166,539 Added 10.17%	1,803,361 $35.9 Million
Q3 2023 Nov 14, 2023	BUY	$16.3 - $22.09 $19.8 Million - $26.8 Million	1,212,266 Added 285.54%	1,636,822 $26.7 Million
Q2 2023 Aug 14, 2023	BUY	$19.41 - $23.43 $3.91 Million - $4.72 Million	201,527 Added 90.36%	424,556 $8.98 Million
Q1 2023 May 15, 2023	SELL	$18.06 - $25.27 $5.7 Million - $7.98 Million	-315,605 Reduced 58.59%	223,029 $4.48 Million
Q4 2022 Feb 14, 2023	BUY	$9.84 - $26.13 $2.35 Million - $6.24 Million	238,634 Added 79.54%	538,634 $14.1 Million
Q3 2022 Nov 14, 2022	BUY	$4.14 - $13.59 $1.24 Million - $4.08 Million	300,000 New	300,000 $3.07 Million

Others Institutions Holding VRNA

# of Institutions

290

Shares Held

74.3M

Call Options Held

933K

Put Options Held

1.98M

View Full List

About Verona Pharma plc

Ticker VRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,954,200
Market Cap $5.49B
Description
Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...

More about VRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account

Janus Henderson Group PLC Verona Pharma PLC Transaction History